HelloBetter

HelloBetter is a Berlin-based digital therapeutics startup that offers courses on prevention (for depression and stress) and treatment (for diabetes and depression, vaginismus, chronic pain, panic, insomnia, alcoholism, and acute depression) of behavioral health conditions. HelloBetter's platform includes features such as an online journal, symptom tracking, and personalized feedback from qualified psychologists within 24 hours on workdays. 

The courses are made available through an access code obtained through a user’s insurance provider and can be accessed either via a desktop or HelloBetter’s mobile app. Users can still apply to enroll themselves in courses even if they are not covered under the specified providers—the platform will then reach out to the insurance provider on the user’s behalf to request reimbursement. The company's courses are structured into multiple units, each taking 45–60 minutes to complete over 12 weeks. In Germany, six of HelloBetter's therapy programs are available as prescription digital therapeutics and are fully reimbursed by statutory health insurance, making them accessible to over 73 million people.

In 2022, the company entered the US market by introducing its Vaginismus Plus DTx for vaginismus (anxiety, pain, and discomfort caused by vaginal penetration) under the new brand name “HelloGina.” In addition, the firm acquired FDA Breakthrough Device Designation for its online panic disorder therapy program as a first step toward securing FDA certification before the product is commercially accessible. 

Key customers and partnerships

The company operates on a B2B2C basis, where it has partnered with insurance providers, such as Barmer, AudiBKK, Allianz, and Swica to facilitate reimbursements.

In 2020, HelloBetter partnered with Allianz to launch a free psychological support program called "Calm through the crisis" during the Covid-19 pandemic. The company has also joined the Digital Therapeutics Alliance to support its international expansion efforts.